NPI: 1679718225 · ORANGE, CA 92868 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,842 | $2.87M |
| 2019 | 43,442 | $2.74M |
| 2020 | 55,369 | $2.81M |
| 2021 | 56,613 | $2.79M |
| 2022 | 43,199 | $2.61M |
| 2023 | 23,465 | $3.47M |
| 2024 | 11,911 | $2.56M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 110,157 | 8,168 | $17.71M | |
| A4657 | Syringe w/wo needle | 3,312 | 2,089 | $883K |
| J0887 | Epoetin beta esrd use | 2,812 | 1,476 | $326K |
| 90945 | 2,483 | 98 | $312K | |
| 0250 | 5,943 | 881 | $207K | |
| J1270 | Injection, doxercalciferol | 48,247 | 4,029 | $198K |
| Q4081 | Epoetin alfa, 100 units esrd | 65,387 | 5,489 | $75K |
| J1756 | Iron sucrose injection | 16,991 | 5,114 | $61K |
| 82728 | 1,638 | 1,467 | $53K | |
| 90674 | 343 | 332 | $8K | |
| 90677 | 17 | 13 | $3K | |
| 90662 | 69 | 67 | $3K | |
| J0604 | Cinacalcet, esrd on dialysis | 1,103 | 242 | $2K |
| 83970 | 1,782 | 1,570 | $2K | |
| G0499 | Hepb screen high risk indiv | 584 | 411 | $1K |
| 90661 | 41 | 41 | $1K | |
| 90747 | 18 | 15 | $1K | |
| 85041 | 2,027 | 1,789 | $735.41 | |
| 82108 | 156 | 141 | $404.86 | |
| 83550 | 1,652 | 1,447 | $122.23 | |
| 83540 | 1,713 | 1,504 | $93.00 | |
| G0008 | Admin influenza virus vac | 99 | 92 | $51.56 |
| 85048 | 2,015 | 1,779 | $36.21 | |
| 0305 | 109 | 45 | $0.00 | |
| 0636 | 1,195 | 86 | $0.00 | |
| 0270 | 76 | 45 | $0.00 | |
| 0301 | 196 | 43 | $0.00 | |
| 0821 | 151 | 133 | $0.00 | |
| 0634 | 1,525 | 100 | $0.00 |